Terms of use
Draft pending legal review. This page describes in plain words what the system does today. It may change before the final version.
The service
Balsamah is a network that connects doctors, pharmacies, drug warehouses and patients to route prescriptions and manage stock. The platform does not prescribe, dispense or treat.
Accounts
- Platform administrators review doctor, pharmacy and warehouse accounts before activation. Patient accounts work immediately.
- Give accurate information and keep your sign-in details private.
- You are responsible for activity that happens under your account.
Medical responsibility
Information in the platform and from the Habba helper is general and is not medical advice. Any decision about diagnosis, dose, or starting or stopping a medicine belongs to the doctor or pharmacist.
Doctors and pharmacists remain responsible for their clinical decisions. In an emergency contact the emergency services.
Stock and availability
A medicine shows as available, low or not available, as entered by the pharmacy. It may not be up to the minute, and the pharmacy confirms availability.
Equivalent medicines
The platform only lists equivalent medicines. A pharmacist or doctor confirms any substitution before dispensing.
Acceptable use
- Do not enter false information.
- Do not try to reach anyone else's data.
- Do not use automated tools to copy content or overload the service.
- Do not misuse the helper.
Paid modules
The core is free. Some modules or subscriptions may be offered for a fee, and prices and billing terms will be shown before you subscribe.
Availability and liability
The service is provided as it is. We work to keep it available but do not promise it will never be interrupted. The final wording on limits of liability will be set in the legal review.
Sources
The disease classification codes shown in the platform are based on ICD-11 © World Health Organization, CC BY-ND 3.0 IGO. Their titles are used for lookup and reference only.
Changes and contact
We may change these terms. The final version, with contact details, will appear after legal review.